Presentation is loading. Please wait.

Presentation is loading. Please wait.

Frequency of the different drug-eluting stent (DES) used over time (2008–2014) according to active drug component and carrier material (groups >1% only).

Published byLaura Navarro Rivas Modified over 6 years ago

Similar presentations

Presentation on theme: "Frequency of the different drug-eluting stent (DES) used over time (2008–2014) according to active drug component and carrier material (groups >1% only)."— Presentation transcript:

1 Frequency of the different drug-eluting stent (DES) used over time (2008–2014) according to active drug component and carrier material (groups >1% only). Frequency of the different drug-eluting stent (DES) used over time (2008–2014) according to active drug component and carrier material (groups >1% only). Multiple selections were possible due to implantation of different stent types during index procedure. Bio-resorbable vascular scaffolds were not included. OPS ‘Operationen- und Prozedurenschlüssel’ (OPS) German version of the International Classification of Procedures in Medicine.19 Elke Jeschke et al. BMJ Open 2017;7:e017460 ©2017 by British Medical Journal Publishing Group

Download ppt "Frequency of the different drug-eluting stent (DES) used over time (2008–2014) according to active drug component and carrier material (groups >1% only)."

Similar presentations

Level of physical activity in individuals reporting experiences of weight discrimination (n=268) and individuals reporting no weight discrimination (n=5212)

Level of physical activity in individuals reporting experiences of weight discrimination (n=268) and individuals reporting no weight discrimination (n=5212)
Number of local authorities (LAs) commissioning each service directly or indirectly (n=148) (*Flu vaccination data excludes the service commissioned across.

Number of local authorities (LAs) commissioning each service directly or indirectly (n=148) (*Flu vaccination data excludes the service commissioned across.
Study sample selection process.

Study sample selection process.
Death, target vessel revascularisation (TVR) and myocardial infarction (MI) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES)

Death, target vessel revascularisation (TVR) and myocardial infarction (MI) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES)
Mean expense per year on courses and conferences that trainees have not been reimbursed. Mean expense per year on courses and conferences that trainees.

Mean expense per year on courses and conferences that trainees have not been reimbursed. Mean expense per year on courses and conferences that trainees.
Daily contribution (%) of sodium and potassium from major food groups among participants aged 8–12 years (n=517), which includes major food groups provided.

Daily contribution (%) of sodium and potassium from major food groups among participants aged 8–12 years (n=517), which includes major food groups provided.
Defining study follow-up periods—index date (entry into cohort) and breaks in MSP registration. †End of follow-up due to earliest of: active TB diagnosis,

Defining study follow-up periods—index date (entry into cohort) and breaks in MSP registration. †End of follow-up due to earliest of: active TB diagnosis,
Steven T. W. van Haelst, MD, Stefanie M. O. Peeters Weem, MD, Frans L

Steven T. W. van Haelst, MD, Stefanie M. O. Peeters Weem, MD, Frans L
Toxicity spectra and rankings in the subgroup analysis based on each specific grade 1-5 adverse event and cancer type. Toxicity spectra and rankings in.

Toxicity spectra and rankings in the subgroup analysis based on each specific grade 1-5 adverse event and cancer type. Toxicity spectra and rankings in.
Scatter graph showing total work time equivalent of all specialist palliative care practitioners commissioned by the Clinical Commissioning Group (CCG)

Scatter graph showing total work time equivalent of all specialist palliative care practitioners commissioned by the Clinical Commissioning Group (CCG)
(A) Indirectly age-sex-deprivation-ethnicity standardised procedure ratios for combined eye injection procedures (OPCS-4: C794 and C893) by CCG in England,

(A) Indirectly age-sex-deprivation-ethnicity standardised procedure ratios for combined eye injection procedures (OPCS-4: C794 and C893) by CCG in England,
DSM-IV delirium prevalence, including the estimated delirium prevalence in the 31 patients that did not undergo delirium assessment following initial screening.

DSM-IV delirium prevalence, including the estimated delirium prevalence in the 31 patients that did not undergo delirium assessment following initial screening.
Scatter graph showing the total number of specialist palliative care beds commissioned compared with the estimated number of people with palliative care.

Scatter graph showing the total number of specialist palliative care beds commissioned compared with the estimated number of people with palliative care.
Estimated probability of successful quitting (quit attempt of longer than 1 year) by quit attempt number in the Ontario Tobacco Survey. Estimated probability.

Estimated probability of successful quitting (quit attempt of longer than 1 year) by quit attempt number in the Ontario Tobacco Survey. Estimated probability.
Trending patterns of life expectancy by sex, SES quintile and remoteness, NSW, 2001–2012. Trending patterns of life expectancy by sex, SES quintile and.

Trending patterns of life expectancy by sex, SES quintile and remoteness, NSW, 2001–2012. Trending patterns of life expectancy by sex, SES quintile and.
Differences in life expectancy by SES, sex and remoteness, NSW, 2001 and 2012. Differences in life expectancy by SES, sex and remoteness, NSW, 2001 and.

Differences in life expectancy by SES, sex and remoteness, NSW, 2001 and Differences in life expectancy by SES, sex and remoteness, NSW, 2001 and.
Any and definite stent thrombosis (ST) and in-device late lumen loss (LLL) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES) in.

Any and definite stent thrombosis (ST) and in-device late lumen loss (LLL) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES) in.
Estimated changes in body mass index (difference in BMI) after October 2010 among nursery schoolchildren born between 2 April 2006 and 1 April 2007 in.

Estimated changes in body mass index (difference in BMI) after October 2010 among nursery schoolchildren born between 2 April 2006 and 1 April 2007 in.
A schematic representation of the possible pairwise comparisons of adherence and persistence between different medication classes. A schematic representation.

A schematic representation of the possible pairwise comparisons of adherence and persistence between different medication classes. A schematic representation.
John A. Bittl et al. JACC 2016;68:

John A. Bittl et al. JACC 2016;68:

Similar presentations

Ads by Google